RU2011101536A - Усовершенствованные пептидные медиаторы оттока холестерина - Google Patents

Усовершенствованные пептидные медиаторы оттока холестерина Download PDF

Info

Publication number
RU2011101536A
RU2011101536A RU2011101536/15A RU2011101536A RU2011101536A RU 2011101536 A RU2011101536 A RU 2011101536A RU 2011101536/15 A RU2011101536/15 A RU 2011101536/15A RU 2011101536 A RU2011101536 A RU 2011101536A RU 2011101536 A RU2011101536 A RU 2011101536A
Authority
RU
Russia
Prior art keywords
polypeptide
group
polypeptide according
mammal
peptidomimetic
Prior art date
Application number
RU2011101536/15A
Other languages
English (en)
Russian (ru)
Inventor
Джон К. БИЛИКИ (US)
Джон К. БИЛИКИ
Ян ЙОХАНССОН (US)
Ян Йоханссон
Original Assignee
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорниа (Us)
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорниа
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Риджентс Оф Дзе Юниверсити Оф Калифорниа (Us), Дзе Риджентс Оф Дзе Юниверсити Оф Калифорниа filed Critical Дзе Риджентс Оф Дзе Юниверсити Оф Калифорниа (Us)
Publication of RU2011101536A publication Critical patent/RU2011101536A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2011101536/15A 2008-06-18 2009-06-17 Усовершенствованные пептидные медиаторы оттока холестерина RU2011101536A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7370808P 2008-06-18 2008-06-18
US61/073,708 2008-06-18

Publications (1)

Publication Number Publication Date
RU2011101536A true RU2011101536A (ru) 2012-07-27

Family

ID=41434685

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011101536/15A RU2011101536A (ru) 2008-06-18 2009-06-17 Усовершенствованные пептидные медиаторы оттока холестерина

Country Status (14)

Country Link
US (1) US8415293B2 (cg-RX-API-DMAC10.html)
EP (1) EP2300038A4 (cg-RX-API-DMAC10.html)
JP (1) JP2011525181A (cg-RX-API-DMAC10.html)
KR (1) KR20110043597A (cg-RX-API-DMAC10.html)
CN (1) CN102123722A (cg-RX-API-DMAC10.html)
AU (1) AU2009260024A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0915422A2 (cg-RX-API-DMAC10.html)
CA (1) CA2727465A1 (cg-RX-API-DMAC10.html)
CL (1) CL2010001445A1 (cg-RX-API-DMAC10.html)
IL (1) IL209868A0 (cg-RX-API-DMAC10.html)
MX (1) MX2010014003A (cg-RX-API-DMAC10.html)
PE (1) PE20110106A1 (cg-RX-API-DMAC10.html)
RU (1) RU2011101536A (cg-RX-API-DMAC10.html)
WO (1) WO2009155366A2 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130123173A1 (en) * 2010-04-28 2013-05-16 The Regents Of The University Of California Creation of oxidation-resistant hdl mimetic peptides
US10017551B2 (en) 2013-03-15 2018-07-10 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
RU2016144908A (ru) 2014-05-02 2018-06-05 Серени Терапеутикс Холдинг Са Маркеры hdl-терапии
WO2016044177A1 (en) * 2014-09-17 2016-03-24 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
US10532105B2 (en) * 2015-07-10 2020-01-14 Peptinovo Biopharma, LLC. Formulations for improving the efficacy of hydrophobic drugs
US11840707B2 (en) 2016-05-31 2023-12-12 Institut De Cardiologie De Montreal Co-culture system and method for in vitro assessment of reverse cholesterol transport
CN110294791B (zh) * 2019-06-13 2023-02-21 倪京满 具有胆固醇外流活性的抗动脉粥样硬化肽类似物及其应用
CN111848742B (zh) * 2020-07-23 2021-03-23 南京医科大学 一种多肽及其制药用途
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备
CN115300609B (zh) * 2021-05-08 2026-07-28 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706131A4 (en) 2003-12-15 2009-08-12 Univ California THE CELLULAR CHOLESTEROL EFFLUX STIMULATING HELICULAR SYNTHETIC PEPTIDES
ATE533783T1 (de) 2006-12-13 2011-12-15 Univ California Potente und selektive mittlersubstanzen von cholesterolefflux

Also Published As

Publication number Publication date
EP2300038A2 (en) 2011-03-30
CL2010001445A1 (es) 2012-03-16
WO2009155366A2 (en) 2009-12-23
IL209868A0 (en) 2011-02-28
CA2727465A1 (en) 2009-12-23
CN102123722A (zh) 2011-07-13
WO2009155366A3 (en) 2010-04-22
JP2011525181A (ja) 2011-09-15
AU2009260024A1 (en) 2009-12-23
PE20110106A1 (es) 2011-03-02
EP2300038A4 (en) 2013-09-04
MX2010014003A (es) 2011-02-15
KR20110043597A (ko) 2011-04-27
US20110190196A1 (en) 2011-08-04
BRPI0915422A2 (pt) 2017-06-27
US8415293B2 (en) 2013-04-09

Similar Documents

Publication Publication Date Title
ES2559927T3 (es) Prevención y reducción de pérdida de sangre y respuesta inflamatoria
JP2004506693A5 (cg-RX-API-DMAC10.html)
NZ628987A (en) Extended recombinant polypeptides and compositions comprising same
RU2006107605A (ru) Пептид (варианты), пара аминокислот, снижающие интенсивность по меньшей мере одного симптома воспалительного состояния, фармацевтическая композиция (варианты), лекарственное средство и фармацевтический набор на их основе
JPH05506252A (ja) 改良トロンビン阻害剤
US12503491B2 (en) MASP inhibitory compounds and uses thereof
WO2012014214A2 (en) Peptides derived from plasminogen activator inhibitor-1 (pai-1) for the treatment of hypertension
JP2011525181A5 (cg-RX-API-DMAC10.html)
JP2010513311A5 (cg-RX-API-DMAC10.html)
CA2232240C (en) Peptide for inhibiting growth of smooth muscle cells
CN101372512B (zh) 一类抗凝血多肽及其用途
CN102123722A (zh) 改进的胆固醇流出的肽介质
Poulter et al. Levitide, a neurohormone-like peptide from the skin of Xenopus laevis. Peptide and peptide precursor cDNA sequences.
JPH03503178A (ja) 改変形質転換成長因子αオリゴペプタイド及びその医薬組成物
WO2008050133A2 (en) Inhibition of beta-amyloid aggregation
US7074892B2 (en) Thrombin generation inhibitors
JP2015160827A (ja) 急性腎障害に起因する多臓器不全の予防又は治療薬
FI120501B (fi) p53-proteiinin pitoisuuksia säätelevien kalpaiinin aktiivisuuden inhibiittorien käyttö syöpälääkkeiden valmistuksessa
WO2011060018A2 (en) Compositions and methods for using peptides, modified peptides, peptidomimetics and fibrin derivatives
US20230174607A1 (en) Novel Adrenomedullin Analog, Method for Producing the Same, and Pharmaceutical Use Thereof
JP4570402B2 (ja) 中枢機能改善剤
RU2840441C2 (ru) Соединения, ингибирующие masp, и их применения
Pavlíčková et al. 15gag proteinase of myeloblastosis-associated virus: specificity studies with substrate-based inhibitors
JP3258639B2 (ja) 新規生理活性ペプチド及びその用途
HK40066330B (en) Masp inhibitory compounds and uses thereof

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20120618